![Daniel Lippis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 30/06/2026
Mr. Daniel J.
Lippis is a VP-Transcatheter Aortic Valve Replacement at Edwards Lifesciences Corp.
He received his undergraduate degree from the University of Adelaide.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 07/07/2026 | 40.034 ( 0,01 % ) | 4 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | 01/01/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Edwards Lifesciences Corp.
 Edwards Lifesciences Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets products to treat late-stage cardiovascular disease | Health Technology |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
